#ESMO26 | 2875O KEYNOTE-975 Pembro or placebo + dCRT in esophageal cancer - EFS: HR 0.97 (CPS ≥10) - OS: HR 1.00 (CPS ≥10) @myESMO @OncoAlert

DaisukeKotani· @DaisukeKotani · X·2026-10-19 06:36· 5 days agoScore60

Body · original

#ESMO26 | 2875O KEYNOTE-975 Pembro or placebo + dCRT in esophageal cancer - EFS: HR 0.97 (CPS ≥10) - OS: HR 1.00 (CPS ≥10) @myESMO @OncoAlert https://t.co/APlJnQ7Fnh

Heat 26 · 17 likes · 0 replies · 9 reposts

Conference abstracts

2875ONCT04210115matched by KEYNOTE-975

KEYNOTE-975 Read the abstract →

NCT04210115NCT04210115matched by - **标题 / Title：** Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

- **标题 / Title：** Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)Read the abstract →

Source: DaisukeKotani · x.com